Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salma K Jabbour

Showing results (1-10 of 223) with videos related to

Pageof 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Are we expanding oligometastatic non-small-cell lung cancer using advanced radiotherapeutic modalities?Salma K Jabbour
Translational Lung Cancer Research|May 22, 2018
Patient-related outcomes with the use of checkpoint inhibitors for the treatment of metastatic non-small cell lung cancerJyoti Malhotra, Salma K Jabbour
International Journal of Radiation Oncology, Biology, Physics|March 16, 2024
Combinatorial Therapies: Embracing Our Multifaceted FutureSalma K Jabbour, Sue S Yom
Journal of the National Cancer Institute|October 18, 2023
Evolving paradigms in locally advanced rectal cancer: the means justify the endsSalma K Jabbour, Howard S Hochster
International Journal of Radiation Oncology, Biology, Physics|October 16, 2022
The Oligometastatic State: Balancing Between Cure and PalliationSalma K Jabbour, Sue S Yom
Journal of Gastrointestinal Oncology|July 20, 2012
Radiation therapy in the postoperative management of esophageal cancerSalma K Jabbour, Charles R Thomas
Journal of Thoracic Disease|August 21, 2018
ALK inhibitors and checkpoint blockade: a cautionary tale of mixing oil with water?Malini Patel, Salma K Jabbour, Jyoti Malhotra
Journal of Thoracic Disease|January 12, 2019
Examining EML4-ALK variants in the clinical setting: the next frontier?Malini Patel, Jyoti Malhotra, Salma K Jabbour
Translational Lung Cancer Research|November 9, 2017
Erratum to current state of immunotherapy for non-small cell lung cancerJyoti Malhotra, Salma K Jabbour, Joseph Aisner
Translational Lung Cancer Research|May 23, 2017
Current state of immunotherapy for non-small cell lung cancerJyoti Malhotra, Salma K Jabbour, Joseph Aisner
Pageof 23

Showing results (1-10 of 223) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Are we expanding oligometastatic non-small-cell lung cancer using advanced radiotherapeutic modalities?Salma K Jabbour
Translational Lung Cancer Research|May 22, 2018
Patient-related outcomes with the use of checkpoint inhibitors for the treatment of metastatic non-small cell lung cancerJyoti Malhotra, Salma K Jabbour
International Journal of Radiation Oncology, Biology, Physics|March 16, 2024
Combinatorial Therapies: Embracing Our Multifaceted FutureSalma K Jabbour, Sue S Yom
Journal of the National Cancer Institute|October 18, 2023
Evolving paradigms in locally advanced rectal cancer: the means justify the endsSalma K Jabbour, Howard S Hochster
International Journal of Radiation Oncology, Biology, Physics|October 16, 2022
The Oligometastatic State: Balancing Between Cure and PalliationSalma K Jabbour, Sue S Yom
Journal of Gastrointestinal Oncology|July 20, 2012
Radiation therapy in the postoperative management of esophageal cancerSalma K Jabbour, Charles R Thomas
Journal of Thoracic Disease|August 21, 2018
ALK inhibitors and checkpoint blockade: a cautionary tale of mixing oil with water?Malini Patel, Salma K Jabbour, Jyoti Malhotra
Journal of Thoracic Disease|January 12, 2019
Examining EML4-ALK variants in the clinical setting: the next frontier?Malini Patel, Jyoti Malhotra, Salma K Jabbour
Translational Lung Cancer Research|November 9, 2017
Erratum to current state of immunotherapy for non-small cell lung cancerJyoti Malhotra, Salma K Jabbour, Joseph Aisner
Translational Lung Cancer Research|May 23, 2017
Current state of immunotherapy for non-small cell lung cancerJyoti Malhotra, Salma K Jabbour, Joseph Aisner
Pageof 23